Early aggressive intervention in cystic fibrosis: is it time to redefine our "best practice" strategies?
Fiel
Stanley B
SB
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000382:microbiology / Q000503:physiopathology; D005541:Forced Expiratory Volume; D006801:Humans; D011552:Pseudomonas Infections / Q000188:drug therapy; D013997:Time Factors
D000900:Anti-Bacterial Agents